Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,600 | -26,000 | 62,700 | 66,200 | 45,200 |
| Depreciation Amortization | 56,600 | 27,300 | 63,100 | 37,100 | 24,700 |
| Income taxes - deferred | -1,300 | -11,400 | 8,600 | 12,800 | 8,500 |
| Accounts receivable | 44,600 | 141,600 | -94,200 | 66,500 | -46,200 |
| Accounts payable and accrued liabilities | 42,600 | 4,200 | -7,000 | -5,700 | -4,400 |
| Other Working Capital | 26,000 | 104,400 | -119,300 | 71,400 | -59,400 |
| Other Operating Activity | -63,900 | -135,300 | 127,900 | -40,700 | 65,200 |
| Operating Cash Flow | $69,000 | $104,800 | $41,800 | $207,600 | $33,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35,500 | -21,400 | -69,500 | -48,700 | -22,600 |
| Net Acquisitions | N/A | N/A | -827,700 | N/A | N/A |
| Other Investing Activity | -10,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-45,500 | $-21,400 | $-897,200 | $-48,700 | $-22,600 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 124,400 | 30,000 | 798,000 | N/A | N/A |
| Debt Repayment | -80,000 | -82,800 | -2,800 | N/A | N/A |
| Common Stock Issued | 4,600 | 900 | N/A | 11,400 | 8,500 |
| Common Stock Repurchased | N/A | N/A | -100 | -100 | -100 |
| Other Financing Activity | -7,300 | -6,500 | -6,400 | -8,500 | -7,300 |
| Financing Cash Flow | $41,700 | $-58,400 | $788,700 | $2,800 | $1,100 |
| Exchange Rate Effect | N/A | N/A | -200 | -600 | -100 |
| Beginning Cash Position | 112,400 | 112,400 | 179,300 | 179,300 | 179,300 |
| End Cash Position | 177,600 | 137,400 | 112,400 | 340,400 | 191,300 |
| Net Cash Flow | $65,200 | $25,000 | $-66,900 | $161,100 | $12,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 69,000 | 104,800 | 41,800 | 207,600 | 33,600 |
| Capital Expenditure | -35,500 | -21,400 | -72,100 | -51,300 | -25,200 |
| Free Cash Flow | 33,500 | 83,400 | -30,300 | 156,300 | 8,400 |